Another pharmacologic currently used as a treatment for type II diabetes, liraglutide, a human glucagon-like peptide 1 (GLP-1) analogue, is currently under investigation as a potential therapeutic for aging and neurodegenerative disorders [314]. This evidence concerns the gene GCG and type 2 diabetes mellitus.